LIVE: FDA Hosts Town Hall on Recent Updates to Biocompatibility Risk Assessment of Medical Devices

Live News Network
1.4K followers
3 Video Views·Sep 9, 2026
The U.S. Food and Drug Administration (FDA) hosts a town hall discussion on the recent updates to the risk-based framework per FDA’s guidance titled “Use of International Standard ISO 10993-1, ‘Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.’” This event is scheduled to begin at 1 p.m. ET on Sept. 9.
AI Generated·May contain errors
Video Summary
AI GeneratedThis presentation by the FDA's CDRH details the transition to the ISO 10993-1:2025 standard for medical device biological evaluation. It emphasizes a shift toward risk management and chemical characterization to reduce animal testing, while clarifying that FDA's existing biocompatibility guidance takes precedence over certain conflicting clauses of the new international standard.
